The clinical role of interferon alpha in Philadelphia-negative myeloproliferative neoplasms-Reference-Cited by-同舟云学术

The clinical role of interferon alpha in Philadelphia-negative myeloproliferative neoplasms

Published:2021-04-30 Issue:S1 Volume:56 Page:S44-S50
ISSN:2287-979X
Container-title:BLOOD RESEARCH
language:en
Short-container-title:Blood Res

Author:

Yoon Seug Yun¹,Won Jong-Ho¹

Affiliation:

1. Division of Hematology & Medical Oncology, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Seoul, Korea

Funder

Soonchunhyang University

Publisher

The Korean Society of Hematology

Subject

Hematology

Link

https://pdf.medrang.co.kr/BR/2021/056/BR2056-00-07.pdf

Reference55 articles.

1. Myeloproliferative neoplasms: from origins to outcomes

2. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

3. SomaticCALRMutations in Myeloproliferative Neoplasms with NonmutatedJAK2

4. MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia

5. Passamonti F, Cazzola M. Cytoreductive therapy for patients with essential thrombocythemia at high risk of thromboembolic complications. The difficult choice of the optimal drug. Haem-atologica 2004;89:1284.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-acting interferon: pioneering disease modification of myeloproliferative neoplasms;The Korean Journal of Internal Medicine;2023-11-01

2. Toxicity of targeted anticancer treatments on the liver in myeloproliferative neoplasms;World Journal of Hepatology;2023-09-27

3. Novel therapeutic strategies for essential thrombocythemia/polycythemia vera;Blood Research;2023-04-30

4. Adverse effects of hydroxyurea used for the treatment of myeloproliferative neoplasms;Journal of the Korean Medical Association;2023-04-10

5. Evaluating ropeginterferon alfa-2b for the treatment of adults with polycythemia vera;Expert Review of Hematology;2023-04-05